Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
24 Leser
Artikel bewerten:
(0)

Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2007


ST. LOUIS, April 30 /PRNewswire-FirstCall/ -- Young Innovations, Inc. today announced results for the quarter ended March 31, 2007.

Sales for the first quarter of 2007 were $22.9 million, an increase of $2.2 million or 10.6% from the $20.7 million reported in the first quarter of 2006. Income from operations declined 15.2% to $4.7 million in the first quarter of 2007 from $5.6 million in the first quarter of 2006. Net income decreased 21.3% to $2.8 million, compared with $3.6 million in the first quarter of 2006. Diluted earnings per share decreased 20.5% in the first quarter of 2007 to $0.31 from $0.39 in the prior year quarter. Diluted earnings per share were affected by equity compensation expense of $0.01 and $0.01 for the quarters ended March 31, 2007 and 2006, respectively.

The results for the quarter were affected by the acquisition of Microbrush, Inc. and Microbrush International, Ltd. (collectively Microbrush) on July 31, 2006 and August 18, 2006, respectively.

Microbrush contributed approximately $3.7 million in sales in the first quarter. The additional sales from Microbrush were partially offset by lower-than-expected sales from new product introductions, ongoing weakness in our panoramic X-ray product line, and a decline in sales to our distributors roughly consistent with our expectations. In addition, increased investments in new product development, personnel and facilities impacted our profitability for the quarter.

Commenting on the quarter, Alfred E. Brennan, Chief Executive Officer, said, "We are disappointed that the results for our X-ray product line and our new product efforts fell below our expectations for the quarter. We remain committed to investing in personnel and infrastructure to support our long-term growth objectives. We expect significant volatility in our results as we respond to the weakness in our X-ray product line and continue to invest in the overall business."

Young Innovations develops, manufactures and markets supplies and equipment used by dentists, dental hygienists, dental assistants and consumers. The Company's product offering includes disposable and metal prophy angles, prophy cups and brushes, dental micro-applicators, panoramic X-ray machines, moisture control products, infection control products, dental handpieces (drills) and related components, endodontic systems, orthodontic toothbrushes, flavored examination gloves, children's toothbrushes, and children's toothpastes. The Company believes it is a leading manufacturer and distributor of prophy angles and cups (used in teeth cleaning and polishing procedures), liquid surface disinfectants, obturation units, and dental micro-applicators in the United States. The Company also believes it is a leading distributor of panoramic X-ray equipment in the United States.

Investors are cautioned that this press release as well as other reports and oral statements by Company officials may contain certain forward-looking statements as defined in the Private Securities Litigation and Reform Act of 1995. Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions and which include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," or similar expressions. These statements are not guaranties of future performance and the Company makes no commitment to update or disclose any revisions to forward-looking statements, or any facts, events or circumstances after the date hereof that may bear upon forward-looking statements. Because such statements involve risks and uncertainties, actual actions and strategies and the timing and expected results thereof may differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, those disclosed in the Company's Annual Report on Form 10-K and other reports filed with the Securities and Exchange Commission.

Young Innovations, Inc. Consolidated Balance Sheet March 31, 2007 and December 31, 2006 (In Thousands) (Unaudited) March 31 December 31 Assets 2007 2006 Current assets Cash $1,083 $1,017 Accounts receivable, net 12,049 13,057 Inventories 15,126 14,111 Other current assets 4,489 5,546 Total current assets 32,747 33,731 Property, plant and equipment, net 31,366 29,178 Goodwill 78,331 78,233 Other intangible assets 10,987 11,140 Other assets 4,144 4,306 Total assets $157,575 $156,588 Liabilities and Equity Current liabilities Accounts payable and accrued liabilities $7,861 $7,749 Total current liabilities 7,861 7,749 Long-term debt 19,438 21,810 Deferred income taxes 10,086 9,531 Total Liabilities 37,385 39,090 Stockholders' equity Common stock 90 90 Additional paid-in capital 26,942 29,214 Retained earnings 113,547 111,089 Common stock in treasury, at cost (20,461) (22,939) Accumulated other comprehensive income 72 44 Total stockholders' equity 120,190 117,498 Total liabilities and stockholders' equity $157,575 $156,588 Young Innovations, Inc. Consolidated Statements of Income (In Thousands, Except Earnings Per Share Data) (Unaudited) Three Months Ended March 31, 2007 2006 Change Net sales $22,883 $20,683 10.6% Cost of goods sold 10,528 9,205 14.4% Gross profit 12,355 11,478 7.6% % of net sales 54.0% 55.5% Selling, general and administrative expenses 7,621 5,894 29.3% % of net sales 33.3% 28.5% Income from operations 4,734 5,584 -15.2% % of net sales 20.7% 27.0% Interest expense (income), net 246 (142) Other income, net (44) (53) Income from operations before provision for income taxes 4,532 5,779 -21.6% Provision for income taxes 1,711 2,192 -21.9% Net income 2,821 3,587 -21.3% % of net sales 12.3% 17.3% Basic earnings per share $0.31 $0.40 -22.5% Basic weighted average shares outstanding 9,065 8,925 Diluted earnings per share $0.31 $0.39 -20.5% Diluted weighted average shares outstanding 9,226 9,240

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2007 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.